-
| CurrencyCode | USD |
|---|---|
| Industry | Biotechnology |
| Sector | Healthcare |
| ISIN | US09610B1089 |
| Exchange | NASDAQ |
| Target Price | 5.5 |
|---|---|
| PE Ratio | None |
| Dividend Yield | 0.0% |
| Market Cap | 17M |
| Beta | nan |
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also develops other products that are under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. Blue Water Vaccines, Inc. was incorporated in 2018 and is based in Cincinnati, Ohio.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BWV using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024